Lifeboat Foundation

Tesla has launched “Tesla Electric” to become an electricity retailer through its Powerwall owners – starting with some markets in Texas.

After gaining experience through its virtual power plants (VPPs), Tesla is taking things a step further with the launch of “Tesla Electric.”

Instead of reacting to specific “events” and providing services to your local electric utilities, like Tesla Powerwall owners have done in VPPs in California, Tesla Electric is actively and automatically buying and selling electricity for Tesla Powerwall owners – providing a buffer against peak prices.

The forecast, first reported by Reuters, represents how some in Silicon Valley are betting the underlying technology will go far beyond splashy and sometimes flawed public demos.

OpenAI was most recently valued at $20 billion in a secondary share sale, one of the sources said. The startup has already inspired rivals and companies building applications atop its generative AI software, which includes the image maker DALL-E 2. OpenAI charges developers licensing its technology about a penny or a little more to generate 20,000 words of text, and about 2 cents to create an image from a written prompt, according to its website.

A spokesperson for OpenAI declined to comment on its financials and strategy. The company, which started releasing commercial products in 2020, has said its mission remains advancing AI safely for humanity.

A gel made of a protein found in human cells can capture particles travelling at supersonic speeds without destroying them on impact, suggesting the material could be used in body armour or for collecting space debris.

No surprises, but confirmation that what we think we should do actually does make a difference. Your brain is really rather amazing. Around 100 billion nerve cells collaborate to keep you nimble and quick-thinking. However, like with the rest of the body, as you age your brain may not be nearly as sharp. You may need to write things down, miss appointments, or have trouble watching TV without straining to understand the dialogue or action.

The speed record for data transmission using a single light source and optical chip has been shattered once again. Engineers have transmitted data at a blistering rate of 1.84 petabits per second (Pbit/s), almost twice the global internet traffic per second.

It’s hard to overstate just how fast 1.84 Pbit/s really is. Your home internet is probably getting a few hundred megabits per second, or if you’re really lucky, you might be on a 1-gigabit or even 10-gigabit connection – but 1 petabit is a million gigabits. It’s more than 20 times faster than ESnet6, the upcoming upgrade to the scientific network used by the likes of NASA.

Even more impressive is the fact this new speed record was set using a single light source and a single optical chip. An infrared laser is beamed into a chip called a frequency comb that splits the light into hundreds of different frequencies, or colors. Data can then be encoded into the light by modulating the amplitude, phase and polarization of each of these frequencies, before recombining them into one beam and transmitting it through optical fiber.

San Diego based biotech Immunicom has developed an innovative therapeutic device that is intended to remove specific factors from blood that prevent our immune systems from fighting disease. Existing “therapeutic apheresis” treatments usually involve modification to cells harvested from patients or some form of plasma exchange. Immunicom’s technology uses a similar treatment procedure but says its approach of “capturing” targeted molecules is very different from other treatments.

Immunicom creates customised molecules that are designed to capture specific proteins or cytokines, but instead of turning those into drugs, it deploys them via its proprietary cartridges, which are essentially small liquid filters that can be fitted into any plasmapheresis machine. In a treatment similar to dialysis, the cartridges are used to treat a patient’s blood and plasma outside their body, reducing the levels of the target factors, with the goal of enabling the immune system to fight disease.

While Immunicom has focused its initial efforts on treatments for cancer, the company claims its technology can also potentially be applied to longevity and the treatment of a wide range of age-related diseases.

The Information has a simple mission: deliver important, deeply reported stories about the technology business you won’t find elsewhere. Many of the most influential people in the industry turn to us for fresh information and original insight.

In this episode, filmed in early 2021, Sam and Peter discuss the creation of OpenAI and GPT-3, what the future of OpenAI will bring to humanity, and the power of AI/Human collaboration.

Sam Altman is the Co-Founder and CEO of OpenAI and former president of Y Combinator. OpenAI is an artificial intelligence research laboratory that creates programs, such as GPT-3, ChatGPT, and DALL-E 2, for the benefit of humanity.

Continue reading “The Rise of OpenAI With Sam Altman (OpenAI CEO) | Moonshots and Mindsets” »